pharma · No medical condition. · Generalized Myasthenia Gravis
Anaxis Pharma
Lacuna Pharma Pty Ltd
Lacuna Pharma Pty is a pharma organization headquartered in Colmenar Viejo, AU. Primary therapeutic focus areas include No medical condition., Generalized Myasthenia Gravis, No therapeutic indication in the current trial
Company details
- Status
- Public
- HQ
- Melbourne, AU
- Founded
- 2017
- Employees
- 7
- Programs
- 642
- Drugs
- 673
- Patents
- 0
Pirfenidone Solution for Inhalation
Phase 2 · small molecule · Interstitial Lung Diseases (ILD), including but not limited to idiopathic pulmonary fibrosis (IPF)
Pirfenidone Solution for Inhalation for Interstitial Lung Diseases (ILD), including but not limited to idiopathic pulmonary fibrosis (IPF) is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code AP01-005
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Lacuna Pharma Pty Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Interstitial Lung Diseases (ILD), including but not limited to idiopathic pulmonary fibrosis (IPF)
- Status
- active
- Trials
- 1